Shots:
The EC has approved the Arexvy RSV vaccine for adults ≥18 yrs in Europe. While it was previously authorized only for adults ≥50 yrs at risk
The adjuvanted RSV vaccine includes a stabilized form of a protein from the respiratory syncytial virus (RSV), called the prefusion F protein (RSVPreF3), combined with GSK’s AS01E adjuvant,…
PharmaShots Magazine's first edition of 2024 is out. Our Jan'24 theme is India’s Role in Global Healthcare! With a market size of $280B in 2020, India is swiftly emerging as a key player in the global healthcare arena. This month's magazine delve into some compelling insights that underscore India's pivotal role in shaping the future…
Shots:
With half of the World's population devoid of primary healthcare facilities, health equity is indeed an indispensable need of the present. With health equity instated, potentially everyone can attain the highest level of health. It means no more deaths from vaccine-preventable diseases, and a healthy equilibrium in the physical, mental, and social aspects of…

